Rhythm Pharmaceuticals, Inc. Common Stock
RYTMRhythm Pharmaceuticals, Inc. (RYTM) is a biotechnology company focused on developing and commercializing therapeutics for rare genetic disorders of appetite regulation. The company is known for its work on treatments targeting hypothalamic obesity and rare metabolic conditions involving the regulation of hunger and energy balance.
Company News
Kuehn Law is investigating whether officers and directors of Rhythm Pharmaceuticals breached fiduciary duties to shareholders through potential self-dealing. Long-term shareholders may be entitled to damages and corporate governance reforms. The law firm is also investigating similar matters at Travere Therapeutics and Viking Therapeutics.
Rhythm Pharmaceuticals (NASDAQ: RYTM) stock surged 5.47% after presenting six-month Phase 2 trial data for setmelanotide in Prader-Willi syndrome patients. The study showed meaningful improvements in BMI (3.06% mean reduction), body composition, hyperphagia, and behavioral measures, with a consistent safety profile. The trial enrolled 18 patients...
Rhythm Pharmaceuticals announced that seven presentations, including four late-breaking abstracts, have been accepted for The Endocrine Society's Annual Meeting (ENDO 2026) in Chicago from June 13-16, 2026. The presentations will showcase clinical trial data for setmelanotide and bivamelagon in treating rare neuroendocrine diseases including Prad...
Rhythm Pharmaceuticals announced that its Chairman, President and CEO David Meeker and CFO Hunter Smith will participate in fireside chats at the Jefferies Global Healthcare Conference (June 4, 2026) and Goldman Sachs 47th Annual Global Healthcare Conference (June 8, 2026), respectively. The company's lead asset IMCIVREE (setmelanotide) is an FDA...
Green Thumb Industries has filed for DEA registration following the rescheduling of marijuana to Schedule III, positioning itself as a first-mover in the evolving U.S. cannabis landscape. The move could attract institutional investors, enable research partnerships, and potentially lead to major stock exchange listings if recreational cannabis is ...
